4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-011854
Chief Operating Officer sold 70,441 shares
- Chief Operating Officer acquired 70,441 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kling Douglas F · Chief Operating Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +56,863 | 100,863 | D |
| 2025-01-29 | Sale : show line 2 in the form 10b5-1 | −56,863 | 44,000 | D |
| 2025-01-30 | Exercise or conversion : show line 3 in the form 10b5-1 | +13,578 | 57,578 | D |
| 2025-01-30 | Sale : show line 4 in the form 10b5-1 | −4,664 | 52,914 | D |
| 2025-01-30 | Sale : show line 5 in the form 10b5-1 | −8,914 | 44,000 | D |
| Open-market sales · 70,441 sh | ||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-29 | Exercise or conversion : show line 6 in the form 10b5-1 Option (right to buy) | −56,863 | 239,723 | D |
| 2025-01-30 | Exercise or conversion : show line 7 in the form 10b5-1 Option (right to buy) | −13,578 | 226,145 | D |
Loading xslF345X05/ownership.xml…